This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- Utility of Radiolabeled Somatostatin Receptor Analogues for Staging/Restaging and Treatment of Somatostatin Receptor-Positive Pediatric Tumors
- The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours
- MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use
- Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
- Somatostatin Receptor Subtype 2 Is Expressed by Supratentorial Primitive Neuroectodermal Tumors of Childhood and Can Be Targeted for Somatostatin Receptor Imaging
- Molecular Biologic and Scintigraphic Analyses of Somatostatin Receptor-Negative Meningiomas
- Peptide Receptor Imaging and Therapy
- Locoregional Regulatory Peptide Receptor Targeting with the Diffusible Somatostatin Analogue 90Y-Labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): A Pilot Study in Human Gliomas